HER2 Support Group Forums - View Single Post - Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

News · 04-08-2013, 12:54 AM

Nektar Therapeutics today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research Annual Meeting.

More...

04-08-2013, 12:54 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,981	Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting Nektar Therapeutics today presented positive preclinical data for NKTR-214, a novel cancer immunotherapy which targets the IL-2 receptor complex, at the 2013 American Association for Cancer Research Annual Meeting. More...